Jocelyn S Thompson1, Daniel D Matlock2, Colleen K McIlvennan3, Amy R Jenkins1, Larry A Allen4. 1. Adult and Child Center for Health Outcomes Research and Delivery Science, University of Colorado School of Medicine, Aurora, Colorado. 2. Adult and Child Center for Health Outcomes Research and Delivery Science, University of Colorado School of Medicine, Aurora, Colorado; Division of General Internal Medicine, University of Colorado School of Medicine, Aurora, Colorado; Colorado Cardiovascular Outcomes Research Consortium, Denver, Colorado. 3. Adult and Child Center for Health Outcomes Research and Delivery Science, University of Colorado School of Medicine, Aurora, Colorado; Colorado Cardiovascular Outcomes Research Consortium, Denver, Colorado; Division of Cardiology, University of Colorado School of Medicine, Aurora, Colorado. 4. Adult and Child Center for Health Outcomes Research and Delivery Science, University of Colorado School of Medicine, Aurora, Colorado; Colorado Cardiovascular Outcomes Research Consortium, Denver, Colorado; Division of Cardiology, University of Colorado School of Medicine, Aurora, Colorado. Electronic address: larry.allen@ucdenver.edu.
Abstract
OBJECTIVES: This study aimed to create decision aids (DAs) for patients considering a destination therapy left ventricular assist device (DT LVAD). BACKGROUND: Insertion of a DT LVAD is a major decision for patients with end-stage heart failure. Patients facing decisions with complex trade-offs may benefit from high-quality decision support resources. METHODS: In accordance with the International Patient Decision Aid Standards guidelines and based on a needs assessment with stakeholders, we developed drafts of paper and video DAs. With input from patients, caregivers, and clinicians through alpha testing, we iteratively modified the DAs to ensure acceptability. RESULTS: We conducted semistructured interviews with 24 patients, 20 caregivers, and 24 clinicians to assess readability, bias, and usability of the DAs. Stakeholder feedback allowed us to integrate aspects critical to decision making around highly invasive therapies for life-threatening diseases, including addressing emotion and fear of death, using gain frames for all options that focus on living, highlighting palliative and hospice care, integrating the caregiver role, and using a range of balanced testimonials. After 19 iterative versions of the paper DA and 4 versions of the video DA, final materials were made available for wider use. CONCLUSIONS: We developed the first International Patient Decision Aid Standards-level DAs for DT LVAD. Given the extreme nature of this medical decision, we augmented traditional DA characteristics with nontraditional DA features to address a spectrum of cognitive, automatic, and emotional aspects of end-of-life decision making. Not only are the DAs important tools for those confronting end-stage heart failure, but the lessons learned will likely inform decision support for other invasive therapies.
OBJECTIVES: This study aimed to create decision aids (DAs) for patients considering a destination therapy left ventricular assist device (DT LVAD). BACKGROUND: Insertion of a DT LVAD is a major decision for patients with end-stage heart failure. Patients facing decisions with complex trade-offs may benefit from high-quality decision support resources. METHODS: In accordance with the International Patient Decision Aid Standards guidelines and based on a needs assessment with stakeholders, we developed drafts of paper and video DAs. With input from patients, caregivers, and clinicians through alpha testing, we iteratively modified the DAs to ensure acceptability. RESULTS: We conducted semistructured interviews with 24 patients, 20 caregivers, and 24 clinicians to assess readability, bias, and usability of the DAs. Stakeholder feedback allowed us to integrate aspects critical to decision making around highly invasive therapies for life-threatening diseases, including addressing emotion and fear of death, using gain frames for all options that focus on living, highlighting palliative and hospice care, integrating the caregiver role, and using a range of balanced testimonials. After 19 iterative versions of the paper DA and 4 versions of the video DA, final materials were made available for wider use. CONCLUSIONS: We developed the first International Patient Decision Aid Standards-level DAs for DT LVAD. Given the extreme nature of this medical decision, we augmented traditional DA characteristics with nontraditional DA features to address a spectrum of cognitive, automatic, and emotional aspects of end-of-life decision making. Not only are the DAs important tools for those confronting end-stage heart failure, but the lessons learned will likely inform decision support for other invasive therapies.
Authors: Matthew C Iacovetto; Daniel D Matlock; Colleen K McIlvennan; Jocelyn S Thompson; William Bradley; Shane J LaRue; Larry A Allen Journal: Circ Cardiovasc Qual Outcomes Date: 2014-10-14
Authors: Molly Magid; Jacqueline Jones; Larry A Allen; Colleen K McIlvennan; Katie Magid; Jocelyn S Thompson; Daniel D Matlock Journal: J Cardiovasc Nurs Date: 2016 May-Jun Impact factor: 2.083
Authors: Annette M O'Connor; John E Wennberg; France Legare; Hilary A Llewellyn-Thomas; Benjamin W Moulton; Karen R Sepucha; Andrea G Sodano; Jaime S King Journal: Health Aff (Millwood) Date: 2007 May-Jun Impact factor: 6.301
Authors: Colleen K McIlvennan; Larry A Allen; Carolyn Nowels; Andreas Brieke; Joseph C Cleveland; Daniel D Matlock Journal: Circ Cardiovasc Qual Outcomes Date: 2014-05-13
Authors: Natalie Joseph-Williams; Robert Newcombe; Mary Politi; Marie-Anne Durand; Stephanie Sivell; Dawn Stacey; Annette O'Connor; Robert J Volk; Adrian Edwards; Carol Bennett; Michael Pignone; Richard Thomson; Glyn Elwyn Journal: Med Decis Making Date: 2013-08-20 Impact factor: 2.583
Authors: Bryan C Wallace; Larry A Allen; Christopher E Knoepke; Russell E Glasgow; Carmen L Lewis; Diane L Fairclough; Laura J Helmkamp; Monica D Fitzgerald; Wendy S Tzou; Daniel B Kramer; Paul D Varosy; Sanjaya K Gupta; John M Mandrola; Scott C Brancato; Pamela N Peterson; Daniel D Matlock Journal: Am Heart J Date: 2020-04-20 Impact factor: 4.749
Authors: Daniel D Matlock; Colleen K McIlvennan; Jocelyn S Thompson; Megan A Morris; Grace Venechuk; Shannon M Dunlay; Shane J LaRue; Eldrin F Lewis; Chetan B Patel; Laura Blue; Erin L Chaussee; Russell E Glasgow; Mary Norine Walsh; Larry A Allen Journal: Med Decis Making Date: 2020-04 Impact factor: 2.583
Authors: Marian E Betz; Christopher E Knoepke; Bonnie Siry; Ashley Clement; Deborah Azrael; Stephanie Ernestus; Daniel D Matlock Journal: Inj Prev Date: 2018-10-13 Impact factor: 2.399
Authors: Nisha Bansal; Susan M Hailpern; Ronit Katz; Yoshio N Hall; Manjula Kurella Tamura; William Kreuter; Ann M O'Hare Journal: JAMA Intern Med Date: 2018-02-01 Impact factor: 21.873
Authors: Laura B Portalupi; Carmen L Lewis; Carl D Miller; Kerry L Whiteman-Jones; Kay A Sather; Donald E Nease; Daniel D Matlock Journal: Fam Pract Date: 2017-06-01 Impact factor: 2.267